Blueprint Medicines Corp Aktie
-
Deine Einschätzung
Blueprint Medicines Corp Aktie
Was spricht für und gegen Blueprint Medicines Corp in den nächsten Jahren?
Pro
Kontra
Rendite von Blueprint Medicines Corp im Vergleich
| Wertpapier | Ver.(%) | 1W | 1M | 1J | YTD | 3J | 5J |
|---|---|---|---|---|---|---|---|
| Blueprint Medicines Corp | - | - | - | - | - | - | - |
| Ligand Pharmaceuticals | -3,55 % | 10,06 % | 7,65 % | 114,13 % | 18,67 % | 200,76 % | 61,74 % |
| United Therapeutics | -0,16 % | 0,55 % | 4,54 % | 95,89 % | 14,84 % | 135,69 % | 188,65 % |
| Ionis Pharmaceuticals Inc. | 0,74 % | -1,70 % | 2,25 % | 167,48 % | -6,21 % | 86,87 % | 85,40 % |
Kommentare
News
Irresistible Change: How to Spot Real Growth
Phil Gilbert, serial entrepreneur and former general manager at IBM, joins this episode of Motley Fool Money to talk about his new book, Irresistible Change: A Blueprint for Earning Buy-In and
Offshore Titans: Transocean Buys Valaris for $5.8B
Transocean Ltd. (NYSE: RIG) has made the definitive move to cement its status as the undisputed leader in offshore drilling. By agreeing to acquire Valaris Limited (NYSE: VAL) in an all-stock
Why Ford's Deal With Amazon Is Bigger Than You Think
Ford Motor Company (NYSE: F) has made a groundbreaking move in automotive retail, announcing a partnership to sell its certified pre-owned (CPO) vehicles directly on Amazon (NASDAQ: AMZN).
This





